ENOV — Enovis CORP

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1420800 ·
Last close
$25.21
Market Cap
$1.45B
52W High
$31.67
52W Low
$19.14
ADV30
1,093,933
Next earnings
2026-11-04
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026
Mar 2026 589,151,000 365,485,000 9,238,000 -8,764,000 3,832,256,000 33,129,000 2,352,764,000
Dec 2025 575,758,000 349,421,000 48,254,000 -520,589,000 3,834,737,000 36,389,000 2,342,835,000
Sep 2025 548,912,000 328,913,000 -8,136,000 -571,146,000 4,433,367,000 33,617,000 2,409,689,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$242,840,000
Investing CF
$-171,947,000
Financing CF
$-77,568,000
CapEx
$-206,918,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-19.26
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,476,227,000
Inventory
$602,543,000
Receivables
$444,206,000
ST Investments
EBIT TTM
$-1,066,631,000
Pretax Income TTM
$-1,101,435,000
Interest Exp TTM
$34,804,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,296,602,880
EBITDA
$379,179,008
Free Cash Flow
$185,567,744
Enterprise Value
$2,861,449,984
Total Cash
$12,563,000
Total Debt
$1,369,048,064
Shares Out
57,669,494
Trailing EPS
$-19.27
Book Value
$25.61
ROE
-54.1%
ROA
1.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,248,049,000 -18,869,000 -1,184,440,000 3,834,737,000 2,342,835,000 217,293,000
Dec 2024 2,107,623,000 -103,429,000 -825,494,000 4,718,777,000 2,154,448,000 113,504,000
Dec 2023 1,707,197,000 -48,374,000 -33,261,000 4,509,334,000 1,088,633,000 134,988,000
Dec 2022 1,563,101,000 -90,658,000 -13,292,000 4,273,248,000 823,447,000 -55,861,000

TTM Snapshot

Revenues TTM
$1,666,483,000
NetIncome TTM
$-75,165,000
OpCashFlow TTM
$0
Assets (Latest)
$4,718,777,000
Forward EPS
$4.01

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $22.50 · spot: $25.21 · call volume: 63 · put volume: 66
Expected Move to 2026-12-18: ±$8.70 (34.51%) — implied range $16.51$33.91 · ATM straddle on $25.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ATEC Alphatec Holdings, Inc. $1.42B $9.24
CDRE Cadre Holdings, Inc. $1.42B $33.08
CNMD CONMED Corp $1.54B $51.49
TNDM TANDEM DIABETES CARE INC $1.55B $22.22
DRTS Alpha Tau Medical Ltd. $1.36B $14.70

News headlines (Yahoo Finance, 1h cache)

Enovis Q2 Earnings Call Highlights
2026-08-08 06:03 · Yahoo
Enovis Corp (ENOV) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 5% Organic ...
2026-08-06 23:17 · Yahoo
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
2026-08-06 11:35 · Yahoo
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates
2026-08-06 10:16 · Yahoo
Is Enovis (ENOV) Signaling a Deeper Shift as Returns on Capital and Sales Decline?
2026-07-30 04:29 · Yahoo
Enovis (ENOV) Faces A Tougher Outlook On Sales Pressure And Undervalued Narrative
2026-07-29 09:07 · Yahoo
UBS starts medtech coverage, favors Intuitive Surgical and Enovis
2026-07-28 13:27 · Yahoo
Enovis (ENOV) Stock Trades Up, Here Is Why
2026-07-13 22:38 · Yahoo
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
2026-07-28 23:57 · Yahoo
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
2026-07-17 20:57 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.